StockWatch
·
Healthcare Research- Analytics & Technology
Quarterly Result29 Apr 2026, 10:41 pm

Syngene Board Approves FY26 Results, Recommends ₹1.25 Dividend

AI Summary

Syngene International Ltd's Board of Directors, at its meeting on April 29, 2026, approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board recommended a final dividend of Re.1.25 per Equity Share of Rs. 10/- for FY2025-26, with the record date set as June 26, 2026. The dividend will be paid within 30 days of shareholder approval. Additionally, M/s S. R. Batliboi & Associates LLP were approved as statutory auditors for a five-year term, subject to shareholder approval. The 33rd Annual General Meeting is scheduled for July 29, 2026.

Key Highlights

  • Board approved audited financial results for Q4 and FY26.
  • Recommended a final dividend of Re.1.25 per equity share for FY26.
  • Record date for dividend payment is fixed as June 26, 2026.
  • M/s S. R. Batliboi & Associates LLP appointed as new statutory auditors for 5 years.
  • 33rd Annual General Meeting to be held on July 29, 2026.